SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it will report its unaudited financial results for the second quarter ended June 30, 2008 on Tuesday, August 5, 2008, before the U.S. financial markets open. ACADIA's management will host a conference call and webcast on Tuesday, August 5, 2008, at 8:30 a.m. Eastern Time to discuss ACADIA’s financial results and development programs.
